arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Alpha Cognition Inc.

ACOG
$8.18 ▼ -0.47 (-5.43%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
4 Visible periods
24 Metrics
Peer-ranked Benchmarks
Price Chart
16
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alpha Cognition Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $144.6M
Dividend Yield —
Revenue Growth —
Op. Margin -221.7%
ROIC -28.6% ↘
FCF / Share $-1.17 ↘
Trailing P/E —
Price / Book 2.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

4-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-20.67M
↓ -41.2% —
FCF / Share Free cash flow per share
$-1.17
↓ -8.9% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
1
Returns
22
Financial Health ↓
2
Cash Quality ↑
66

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 4 years · 18 quarters